Abiomed to Present at Bank of America Merrill Lynch 2013 Health Care Conference

Abiomed to Present at Bank of America Merrill Lynch 2013 Health Care
Conference

DANVERS, Mass., May 8, 2013 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a
leading provider of breakthrough heart support technologies, today announced
that Susan V. Lisa, Senior Director, Investor Relations and Corporate
Development, will present at the Bank of America Merrill Lynch 2013 Health
Care Conference on Wednesday, May 15, 2013 at 9:20 a.m. PT. The conference
will be held at Encore at the Wynn in Las Vegas, Nevada.

ABOUT ABIOMED

Based in Danvers, Massachusetts, Abiomed, Inc., is a leading provider of
medical devices that provide circulatory support. Our products are designed to
enable the heart to rest by improving blood flow and/or performing the pumping
of the heart. For additional information please visit: www.abiomed.com

FORWARD-LOOKING STATEMENTS

This release contains forward-looking statements, including statements
regarding development of Abiomed's existing and new products, the Company's
progress toward commercial growth, and future opportunities and expected
regulatory approvals. The Company's actual results may differ materially from
those anticipated in these forward-looking statements based upon a number of
factors, including uncertainties associated with development, testing and
related regulatory approvals, including the potential for future losses,
complex manufacturing, high quality requirements, dependence on limited
sources of supply, competition, technological change, government regulation,
litigation matters, future capital needs and uncertainty of additional
financing, and other risks and challenges detailed in the Company's filings
with the Securities and Exchange Commission, including the most recently filed
Annual Report on Form 10-K and quarterly report on Form 10-Q. Readers are
cautioned not to place undue reliance on any forward-looking statements, which
speak only as of the date of this release. The Company undertakes no
obligation to publicly release the results of any revisions to these
forward-looking statements that may be made to reflect events or circumstances
that occur after the date of this release or to reflect the occurrence of
unanticipated events.

CONTACT: For further information please contact:
         Susie Lisa, CFA
         Senior Director, Investor Relations and Corporate Development
         978-646-1590
         slisa@abiomed.com
        
         Aimee Maillett
         Corporate Communications Manager
         978-646-1553
         ir@abiomed.com

Abiomed Logo
 
Press spacebar to pause and continue. Press esc to stop.